| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2K | -1.0% |
| R&D Expense | $567K | -20.8% |
| SG&A Expense | $419K | +307.9% |
| Operating Income | -$1.2M | -44.2% |
| Interest Expense | $11K | -36.2% |
| Pre-tax Income | -$1.2M | -42.5% |
| Net Income | -$1.2M | -42.5% |
| EPS (Basic) | -$0.20 | -25.0% |
| EPS (Diluted) | -$0.20 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | +172.2% |
| Current Assets | $1.2M | +172.9% |
| Total Assets | $1.2M | +170.5% |
| Current Liabilities | $91K | -63.4% |
| Total Liabilities | $91K | -63.4% |
| Stockholders' Equity | $1.1M | +494.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -33.3% |
| Capital Expenditures | $6K | +0.0% |
| Investing Cash Flow | -$6K | +0.0% |
| Financing Cash Flow | $1.8M | +74.0% |
| Free Cash Flow | -$1.1M | -33.0% |
| -25.0% |